First German haemophilia B patient receives gene therapy HEMGENIX https://pharmatimes.com/news/f....irst-german-haemophi

Sandoz Recalls Cefazolin Due to Mispackaging, Opens Biosimilar Facility in Slovenia The company is voluntarily recalling one lot of cefazolin for injection, USP, 1 gram per vial due to customer complaints of the wrong product being included in a carton.
https://www.pharmtech.com/view..../sandoz-recalls-cefa

Piramal Pharma Holds Groundbreaking at Kentucky Facility, Part of $90 Million Investment Plan The expansion of the Kentucky site accounts for $80 million of the announced investment, with the remaining money earmarked for facilities in Michigan.
https://www.pharmtech.com/view..../piramal-pharma-hold

Neumifil shows promise in treating influenza with positive phase 2 dat https://pharmatimes.com/news/n....eumifil-shows-promis

Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More Sascha Berger, private biopharmaceutical investor; Shannon Eaker, CTO of Xcellbio; Edwin Stone, CEO of Cellular Origins; and Bryce Sady, VP of Product Development at PSL Group go behind the headlines to talk CAR-T advancements, exciting M&A developments, and the impact of lost research funding on innovation.
https://www.pharmtech.com/view..../behind-the-headline